You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 8, August 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Corneal Disorders
 •Alert me on articles by topic

Unusual Phenotype of an Individual With the R124C Mutation in the TGFBI Gene

Arch Ophthalmol. 2004;122:1224-1227.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We describe here an unusual phenotype associated with the arginine-124->cysteine (R124C) mutation of the TGFBI gene. The proband was a 44-year-old woman who exhibited translucent lattice lines and circular central epithelial opacity in both corneas and who had a typical history of recurrent corneal erosions. She and members of her family harbored the R124C mutation of TGFBI, which has been implicated as a genetic change responsible for lattice corneal dystrophy (LCD) type I. We performed keratoplasty on her left eye and examined the removed tissue histopathologically. Light microscopy revealed deposition of mucopolysaccharide and disruption of the Bowman layer, but no Congo red–positive component was detected. Furthermore, apple-green dichroism was not apparent with polarized microscopy. Electron microscopy revealed numerous vacuoles within keratocytes as well as separated collagen fibrils, but no amyloid fibrils, in the stroma. The R124C mutation of TGFBI is thus not necessarily associated with amyloid deposition.

Point . . . [Full Text of this Article]

Report of a Case


Comment
Naoyuki Morishige, MD, PhD; Tai-ichiro Chikama, MD, PhD; Yoshitsugu Ishimura, MD; Teruo Nishida, MD, DSc; Mutsuo Takahashi, MD, PhD; Yukihiko Mashima, MD

Correspondence: Dr Morishige, Department of Biomolecular Recognition and Ophthalmology, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan (morishig@yamaguchi-u.ac.jp).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.